Phase 1 Anxiety Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
Open-Label Psilocybin Study in Transdiagnostic Population
AnxietyDepression - Major Depressive DisorderPTSD+5 more
Yale University50 enrolled1 locationNCT06442423
Recruiting
Phase 1
Intraoperative Midazolam on Delirium Outcome of Elderly Patients
AnxietyDelirium
Chinese PLA General Hospital612 enrolled1 locationNCT06963112
Recruiting
Phase 1
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
Depression, AnxietyAnxietyDepression - Major Depressive Disorder+1 more
Trustees of Dartmouth College15 enrolled1 locationNCT06920238
Recruiting
Phase 1Phase 2
Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Depression Anxiety DisorderKidney Failure, ChronicAnemia in End Stage Renal Disease
Mansoura University46 enrolled1 locationNCT06917950
Recruiting
Phase 1
The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on Anxiety
AnxietyMedication-refractory Focal-onset Epilepsy
Ohio State University10 enrolled1 locationNCT05032105
Recruiting
Phase 1
Affect of Duavive on Mood & Anxiety Symptoms
MenopauseDepression, AnxietySleep+1 more
St. Joseph's Healthcare Hamilton30 enrolled1 locationNCT04478305
Recruiting
Phase 1Phase 2
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)
Depression, AnxietyDistress, Emotional
Ottawa Hospital Research Institute20 enrolled2 locationsNCT04754061